Vincerx Pharma, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Palo Alto, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Vincerx Pharma, Inc. has filed 371 SEC EDGAR filings since 12 Dec 2019

SEC filing history

Showing 176-200 of 371 matching filings.

Per page
25
Current page
8
4

FORM 4 SUBMISSION

Filing date
31 May 2022
Reporting date
26 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
31 May 2022
Reporting date
26 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-39244

DEFA14A

Filing date
12 Apr 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-39244

DEF 14A

Filing date
12 Apr 2022
Reporting date
26 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-263929

S-8

Filing date
29 Mar 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Feb 2022
Reporting date
14 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Feb 2022
Reporting date
14 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Feb 2022
Reporting date
14 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Feb 2022
Reporting date
14 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Feb 2022
Reporting date
14 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Feb 2022
Reporting date
14 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Feb 2022
Reporting date
14 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91457

AMENDMENT NO. 1

Filing date
14 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91457

SC 13G/A filing

Filing date
14 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91457

VINCERX PHARMA, INC.

Filing date
14 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91457

AMENDED SC 13G

Filing date
11 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91457

VINCERX PHARMA, INC.

Filing date
10 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
31 Jan 2022
Reporting date
20 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-262239

EFFECT filing

Filing date
28 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-262239

424B3

Filing date
28 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
26 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .